<DOC>
	<DOCNO>NCT01822977</DOCNO>
	<brief_summary>The investigator hypothesis daily use proton pump inhibitor ( PPI ) associate significant alteration healthy fecal microbiome similar see person initial episode clostridium difficile infection ( CDI ) .</brief_summary>
	<brief_title>The Impact Proton Pump Inhibitors Fecal Microbiome</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Table 1 . Inclusion Criteria Healthy Volunteers : 1 . Healthy individual without chronic gastrointestinal problem use antisecretory medication . Table 2 . Inclusion Criteria Clostridium difficile infection subject : 1 . Newly diagnose first episode CDI prior treat . Table 3 . Exclusion Criteria Healthy Subjects : 1 . Prior gastrointestinal surgery alter anatomy esophagus , stomach , small/large intestine include appendectomy cholecystectomy . 2 . Chronic daily use medication could alter gastrointestinal secretory motor function ( see Table 2 ) . 3 . Gastrointestinal , cardiovascular , endocrine , renal , chronic disease likely affect gastrointestinal motility ( e.g. , uncontrolled diabetes mellitus ) . 4 . Females childbearing age practice least one form birth control least one month prior start PPI pregnant lactating ( pregnancy test perform female subject prior PPI use ) . 5 . Significant untreated psychiatric disease . Table 4 . Prohibited Medications : 1 . Antibiotics within 2 month stool sample collection . 2 . Probiotics ( e.g. , Florastor , Align , FloraQ , VSL # 3 , lactobacillus , bifidobacterium ) within 2 week stool sample collection . 3 . Fiber supplement ( e.g. , Metamucil , Citrucel , Benefiber ) , unless maintain stable dose last 3 month . 4 . Chronic use medication alter gastric pH : proton pump inhibitor ( e.g. , omeprazole , lansoprazole , esomeprazole , pantoprazole , rabeprazole , dexlansoprazole ) histamine2 receptor antagonist ( e.g. , cimetidine , famotidine , ranitidine ) . 5 . Chronic use medication affect gastrointestinal motility and/or transit include prokinetic agent ( e.g. , metoclopramide ( Reglan ) , tegaserod ( Zelnorm ) , domperidone ( Motilium ) , erythromycin ) , narcotic analgesic agent ( e.g. , methadone , fentanyl , oxycodone , codeine , morphine , hydromorphone ) , laxatives include mineral oil , anticholinergic agent ( e.g. , Bentyl , Levsin ) , antidiarrheal agent ( e.g. , Kaopectate ( donnagel ) , PeptoBismol ( bismuth subsalicylate ) , Imodium ( loperamide ) , Lomotil ( atropine diphenoxylate ) , codeine , tincture opium ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>gut microbiota</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>Clostridium difficile infection</keyword>
	<keyword>Fecal microbiome</keyword>
	<keyword>single episode CDI</keyword>
</DOC>